• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction.个体长链n-3脂肪酸的血液浓度与非致命性心肌梗死风险
Am J Clin Nutr. 2008 Jul;88(1):216-23. doi: 10.1093/ajcn/88.1.216.
2
n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study.n-3多不饱和脂肪酸、老年人致命性缺血性心脏病和非致命性心肌梗死:心血管健康研究
Am J Clin Nutr. 2003 Feb;77(2):319-25. doi: 10.1093/ajcn/77.2.319.
3
Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study.循环长链 ω-3 脂肪酸与老年人充血性心力衰竭的发生:心血管健康研究:一项队列研究。
Ann Intern Med. 2011 Aug 2;155(3):160-70. doi: 10.7326/0003-4819-155-3-201108020-00006.
4
Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.血浆磷脂长链 ω-3 脂肪酸与老年人的全因和死因特异性死亡率:一项队列研究。
Ann Intern Med. 2013 Apr 2;158(7):515-25. doi: 10.7326/0003-4819-158-7-201304020-00003.
5
ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies.ω-3 多不饱和脂肪酸生物标志物与冠心病:19 项队列研究的汇总项目。
JAMA Intern Med. 2016 Aug 1;176(8):1155-66. doi: 10.1001/jamainternmed.2016.2925.
6
Exploring the association between whole blood Omega-3 Index, DHA, EPA, DHA, AA and n-6 DPA, and depression and self-esteem in adolescents of lower general secondary education.探讨下等普通中等教育青少年全血欧米伽 3 指数、二十二碳六烯酸、二十碳五烯酸、二十二碳六烯酸、花生四烯酸与 n-6 二十二碳五烯酸和抑郁、自尊之间的关系。
Eur J Nutr. 2019 Jun;58(4):1429-1439. doi: 10.1007/s00394-018-1667-4. Epub 2018 Mar 16.
7
Association between n-3 polyunsaturated fatty acids in erythrocytes and metabolic syndrome in Chinese men and women.中国男性和女性红细胞中n-3多不饱和脂肪酸与代谢综合征之间的关联。
Eur J Nutr. 2016 Apr;55(3):981-9. doi: 10.1007/s00394-015-0912-3. Epub 2015 May 3.
8
n-3 Docosapentaenoic Acid Intake and Relationship with Plasma Long-Chain n-3 Fatty Acid Concentrations in the United States: NHANES 2003-2014.美国n-3二十二碳五烯酸摄入量及其与血浆长链n-3脂肪酸浓度的关系:2003 - 2014年美国国家健康与营养检查调查(NHANES)
Lipids. 2019 Apr;54(4):221-230. doi: 10.1002/lipd.12146.
9
Association between serum long-chain omega-3 polyunsaturated fatty acids and cognitive performance in elderly men and women: The Kuopio Ischaemic Heart Disease Risk Factor Study.老年男性和女性血清长链ω-3多不饱和脂肪酸与认知功能的关联:库奥皮奥缺血性心脏病危险因素研究
Eur J Clin Nutr. 2016 Aug;70(8):970-5. doi: 10.1038/ejcn.2016.59. Epub 2016 Apr 13.
10
Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the Kuopio Ischemic Heart Disease Risk Factor study.血清 ω-3 多不饱和脂肪酸与男性 2 型糖尿病发病风险:库奥皮奥缺血性心脏病风险因素研究。
Diabetes Care. 2014;37(1):189-96. doi: 10.2337/dc13-1504. Epub 2013 Sep 11.

引用本文的文献

1
Circulating Omega-3 Polyunsaturated Fatty Acids Levels in Coronary Heart Disease: Pooled Analysis of 36 Observational Studies.冠心病患者循环ω-3 多不饱和脂肪酸水平:36 项观察性研究的汇总分析。
Nutrients. 2024 May 24;16(11):1610. doi: 10.3390/nu16111610.
2
Current Evidence and Future Directions of Omega-3 Supplementation and Cardiovascular Disease Risk.ω-3补充剂与心血管疾病风险的当前证据及未来方向
Int J Angiol. 2023 Nov 24;33(1):1-7. doi: 10.1055/s-0043-1777258. eCollection 2024 Feb.
3
Investigating the catalytic efficiency of C22-Fatty acids with LOX human isozymes and the platelet response of the C22-oxylipin products.研究 C22-脂肪酸与 LOX 同工酶的催化效率及 C22-氧化脂素产物对血小板的反应。
Arch Biochem Biophys. 2023 Oct 1;747:109742. doi: 10.1016/j.abb.2023.109742. Epub 2023 Sep 9.
4
Comparison of dimension reduction methods on fatty acids food source study.脂肪酸食物来源研究中降维方法的比较。
Sci Rep. 2021 Sep 21;11(1):18748. doi: 10.1038/s41598-021-97349-6.
5
The influence of nutritional state on the fatty acid composition of circulating lipid fractions: implications for their use as biomarkers of dietary fat intake.营养状态对循环脂质组分中脂肪酸组成的影响:对其作为膳食脂肪摄入量生物标志物的应用的启示。
Ups J Med Sci. 2021 Jul 13;126. doi: 10.48101/ujms.v126.7649. eCollection 2021.
6
Fatty acids and cardiometabolic health: a review of studies in Chinese populations.脂肪酸与心脏代谢健康:中国人群相关研究综述。
Eur J Clin Nutr. 2021 Feb;75(2):253-266. doi: 10.1038/s41430-020-00709-0. Epub 2020 Aug 14.
7
The Short Overview on the Relevance of Fatty Acids for Human Cardiovascular Disorders.脂肪酸与人类心血管疾病相关性概述
Biomolecules. 2020 Jul 30;10(8):1127. doi: 10.3390/biom10081127.
8
Genetics of Omega-3 Long-Chain Polyunsaturated Fatty Acid Metabolism and Meat Eating Quality in Tattykeel Australian White Lambs.ω-3 长链多不饱和脂肪酸代谢与塔斯马尼亚澳洲白羔羊肉质的遗传学研究。
Genes (Basel). 2020 May 25;11(5):587. doi: 10.3390/genes11050587.
9
Comparison of the Utility of Total Plasma Fatty Acids Versus those in Cholesteryl Ester, Phospholipid, and Triglyceride as Biomarkers of Fatty Acid Intake.总血浆脂肪酸与胆固醇酯、磷脂和甘油三酯中脂肪酸作为脂肪酸摄入量生物标志物的效用比较。
Nutrients. 2019 Sep 3;11(9):2081. doi: 10.3390/nu11092081.
10
n-3 Docosapentaenoic Acid Intake and Relationship with Plasma Long-Chain n-3 Fatty Acid Concentrations in the United States: NHANES 2003-2014.美国n-3二十二碳五烯酸摄入量及其与血浆长链n-3脂肪酸浓度的关系:2003 - 2014年美国国家健康与营养检查调查(NHANES)
Lipids. 2019 Apr;54(4):221-230. doi: 10.1002/lipd.12146.

本文引用的文献

1
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.二十碳五烯酸对高胆固醇血症患者主要冠脉事件的影响(日本 EPA 脂质干预研究):一项随机开放标签、终点设盲的分析。
Lancet. 2007 Mar 31;369(9567):1090-8. doi: 10.1016/S0140-6736(07)60527-3.
2
Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel.英国男性冠心病的二级预防:饮食与再梗死试验及其后续研究。
Proc Nutr Soc. 2007 Feb;66(1):9-15. doi: 10.1017/S0029665107005241.
3
Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients.中年急性冠状动脉综合征患者血液中的ω-3脂肪酸和反式脂肪酸
Am J Cardiol. 2007 Jan 15;99(2):154-8. doi: 10.1016/j.amjcard.2006.08.013. Epub 2006 Nov 17.
4
Fish intake, contaminants, and human health: evaluating the risks and the benefits.鱼类摄入、污染物与人类健康:评估风险与益处
JAMA. 2006 Oct 18;296(15):1885-99. doi: 10.1001/jama.296.15.1885.
5
Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids.ω-3脂肪酸的抗动脉粥样硬化和抗血栓形成作用。
Am J Cardiol. 2006 Aug 21;98(4A):39i-49i. doi: 10.1016/j.amjcard.2005.12.026. Epub 2006 May 30.
6
Distribution, interconversion, and dose response of n-3 fatty acids in humans.人体内n-3脂肪酸的分布、相互转化及剂量反应
Am J Clin Nutr. 2006 Jun;83(6 Suppl):1467S-1476S. doi: 10.1093/ajcn/83.6.1467S.
7
Risks and benefits of omega 3 fats: a few thoughts on systematic review.欧米伽3脂肪酸的风险与益处:关于系统评价的几点思考
BMJ. 2006 Apr 15;332(7546):915; discussion 915-6. doi: 10.1136/bmj.332.7546.915-a.
8
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review.ω-3脂肪酸对心血管疾病风险血清标志物的影响:一项系统综述。
Atherosclerosis. 2006 Nov;189(1):19-30. doi: 10.1016/j.atherosclerosis.2006.02.012. Epub 2006 Mar 10.
9
Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I.日本人摄入鱼类和n-3脂肪酸与冠心病风险:基于日本公共卫生中心的(JPHC)队列研究I
Circulation. 2006 Jan 17;113(2):195-202. doi: 10.1161/CIRCULATIONAHA.105.581355. Epub 2006 Jan 9.
10
A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models.ω-3脂肪酸对动物模型中特定心律失常结局影响的系统评价和荟萃分析。
Metabolism. 2005 Dec;54(12):1557-65. doi: 10.1016/j.metabol.2005.05.026.

个体长链n-3脂肪酸的血液浓度与非致命性心肌梗死风险

Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction.

作者信息

Sun Qi, Ma Jing, Campos Hannia, Rexrode Kathryn M, Albert Christine M, Mozaffarian Dariush, Hu Frank B

机构信息

Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA.

出版信息

Am J Clin Nutr. 2008 Jul;88(1):216-23. doi: 10.1093/ajcn/88.1.216.

DOI:10.1093/ajcn/88.1.216
PMID:18614744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6598701/
Abstract

BACKGROUND

Whereas dietary intake of long-chain n-3 fatty acids has been associated with risk of nonfatal myocardial infarction (MI), few studies have examined the relation for blood concentrations.

OBJECTIVE

We aimed to investigate the effect of long-chain n-3 fatty acids in blood on the risk of nonfatal MI.

DESIGN

Baseline blood samples were collected from 32 826 participants of the Nurses' Health Study in 1989-1990, among whom 146 incident cases of nonfatal MI were ascertained during 6 y of follow-up and matched with 288 controls.

RESULTS

After multivariate adjustment, the relative risks (95% CI) comparing the highest with the lowest quartiles in plasma were 0.23 (0.09, 0.55; P for trend = 0.001) for eicosapentaenoic acid (EPA), 0.40 (0.20, 0.82; P for trend = 0.004) for docosapentaenoic acid (DPA), and 0.46 (0.18, 1.16; P for trend = 0.07) for docosahexaenoic acid (DHA). The associations for these fatty acids in erythrocytes were generally weaker and nonsignificant. In contrast to EPA and DHA, blood concentrations of DPA were not correlated with dietary consumption of n-3 fatty acids. Higher plasma concentrations of EPA, DPA, and DHA were associated with higher plasma concentrations of HDL cholesterol and lower concentrations of triacylglycerol and inflammatory markers.

CONCLUSIONS

Higher plasma concentrations of EPA and DPA are associated with a lower risk of nonfatal MI among women. These findings may partly reflect dietary consumption but, particularly for DPA, may indicate important risk differences based on metabolism of long-chain n-3 fatty acids.

摘要

背景

尽管长链n-3脂肪酸的饮食摄入量与非致命性心肌梗死(MI)风险相关,但很少有研究探讨血液浓度之间的关系。

目的

我们旨在研究血液中长链n-3脂肪酸对非致命性MI风险的影响。

设计

1989年至1990年从32826名护士健康研究参与者中采集基线血样,其中在6年随访期间确定了146例非致命性MI事件,并与288名对照进行匹配。

结果

多变量调整后,血浆中二十碳五烯酸(EPA)最高四分位数与最低四分位数相比的相对风险(95%CI)为0.23(0.09,0.55;趋势P值=0.001),二十二碳五烯酸(DPA)为0.40(0.20,0.82;趋势P值=0.004),二十二碳六烯酸(DHA)为0.46(0.18,1.16;趋势P值=0.07)。红细胞中这些脂肪酸的关联通常较弱且无统计学意义。与EPA和DHA不同,DPA的血液浓度与n-3脂肪酸的饮食摄入量无关。较高的血浆EPA、DPA和DHA浓度与较高的血浆高密度脂蛋白胆固醇浓度以及较低的三酰甘油和炎症标志物浓度相关。

结论

较高的血浆EPA和DPA浓度与女性非致命性MI风险较低相关。这些发现可能部分反映饮食摄入情况,但特别是对于DPA,可能表明基于长链n-3脂肪酸代谢的重要风险差异。